Novakand Pharma AB (publ) - Asset Resilience Ratio
Novakand Pharma AB (publ) (LARK) has an Asset Resilience Ratio of 5.32% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Novakand Pharma AB (publ) (LARK) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how Novakand Pharma AB (publ)'s Asset Resilience Ratio has changed over time. See Novakand Pharma AB (publ) free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Novakand Pharma AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Novakand Pharma AB (publ) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr3.06 Million | 5.32% |
| Total Liquid Assets | Skr3.06 Million | 5.32% |
Asset Resilience Insights
- Limited Liquidity: Novakand Pharma AB (publ) maintains only 5.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Novakand Pharma AB (publ) Industry Peers by Asset Resilience Ratio
Compare Novakand Pharma AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hermana Holding ASA
OL:HERMA |
Asset Management | 92.46% |
|
Bajaj Holdings & Investment Limited
NSE:BAJAJHLDNG |
Asset Management | 1.12% |
|
Australian Foundation Investment Company Ltd
AU:AFI |
Asset Management | 0.01% |
|
KBC Ancora
BR:KBCA |
Asset Management | 1.63% |
|
Caitong Securities Co Ltd
SHG:601108 |
Asset Management | 13.57% |
|
Argo Investments Ltd
AU:ARG |
Asset Management | 0.46% |
|
Strive, Inc.
NASDAQ:ASST |
Asset Management | 3.11% |
|
L1 Group Limited
AU:L1G |
Asset Management | 21.83% |
Annual Asset Resilience Ratio for Novakand Pharma AB (publ) (2025–2025)
The table below shows the annual Asset Resilience Ratio data for Novakand Pharma AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.73% | Skr3.25 Million ≈ $349.54K |
Skr56.73 Million ≈ $6.11 Million |
-- |
About Novakand Pharma AB (publ)
Lärkberget AB (publ) operates as an investment company. The company is involved in direct investments in low-risk instruments, and unlisted profitable companies; financial investments; and reverse acquisition business. It also invests in listed shares, funds and other liquid asset classes, as well as participates in bridge loans and guarantee commitments. The company was formerly known as CombiGe… Read more